News

德特威勒新闻动态

我们重视坦诚对话和有透明度的沟通。 我们会定期向客户、股东和公众通报公司最重要的发展情况。在这里,您可以选择感兴趣的新闻类别进行查看,例如媒体报道、技术文章展会活动、 线上研讨会报告、 公报 或 特别公告

61 查找结果 for "innovation" 清空筛选

Datwyler Realigns Executive Board and Sharpens Customer-Focused Innovation
News | 01.04.2026

Datwyler announces changes to its Executive Board in order to strengthen its organization and set a clear course for the future.

Datwyler AGM approves all proposals of the Board
News | 18.03.2026

The 68th Annual General Meeting of Dätwyler Holding Inc. was held in Altdorf on Tuesday, 17 March 2026. Share-holders approved all Board proposals by a large majority.

Datwyler Successfully Completes Acquisition of Majority Stake in Capsul’in
News | 18.02.2026

Datwyler has successfully completed the acquisition of a majority stake in Capsul’in as announced in December 2025.

Annual Results 2025
Ad hoc announcement | 12.02.2026

In the 2025 financial year, Datwyler generated revenue of CHF 1'100.5 million. Adjusted for negative currency effects of -3.7%, the company achieved organic growth of 3.1%. Due to these currency effects, reported revenue was overall 0.6% below the prior-year level.

Collaboration Datwyler, LTS Device Technologies and Stevanato Group
Article | 16.01.2026

Datwyler announced a collaboration with LTS Device Technologies, a developer of smart wearable devices for drug delivery, and Stevanato Group

Datwyler strenghten its leadership position
特别公告. | 19.12.2025

Datwyler has signed an agreement to acquire 51% of Capsul’Invest SA und Brain Corp SA (together operating as Capsul’in), a leading provider of aluminum coffee capsule solutions headquartered in Luxembourg with annual revenues of approximately EUR 90 million.

SoftPulse Turn Insights into Solutions
Article | 18.09.2025

Wearables have become a major driver of innovation in personalized healthcare in recent years. Learn more about how we turn insights into solutions through our solution design approach on the example of SoftPulse® Flex

Half-Year Results 2025
特别公告. | 22.07.2025

尽管外部环境充满挑战,德特威勒在2025年上半年依然实现了增长势头。

Start of serial component supply for GLP-1 therapy
新闻 | 02.04.2025

德特威勒通过启动GLP-1注射疗法高端包装组件的批量供应,进一步巩固其市场地位并推动增长。这体现了其在快速扩张的注射剂市场中所做的战略投资及早期开发合作伙伴关系。

Sealing solutions for hydrogen production
技术文章 | 13.02.2025

Datwyler's specialized sealing solutions ensure the efficient and reliable operation of electrolyzers and auxiliary systems.

Annual Results 2024
Ad hoc announcement | 06.02.2025

Datwyler slightly increased its EBIT margin in 2024 despite weak markets and a slight decline in revenue. The transformation program «ForwardNow» will accelerate the planned profitable growth.

Launch Transformation Program ForwardNow
Ad hoc announcement | 18.12.2024

Datwyler is launching a transformation program for the period 2025 to 2027 to accelerate revenue and profitability growth.

Battery Cell Sealing
技术文章 | 20.11.2024

电芯密封会影响电池的机械稳定性和热管理性能,它对于在各种工况条件下电池保持最佳性能至关重要。

Launch of NeoFlex™ Plungers for Large Volume Biologics
新闻 | 08.10.2024

德特威勒推出 NeoFlex™ 活塞,适用于大容量生物制剂的自动注射器和可穿戴式注射器。

Advanced sealing solutions for a sustainable future
技术文章 | 21.08.2024

随着世界向可持续能源系统的转型,绿色氢能正迅速成为未来能源战略的基石。

Half-Year Results 2024
Datwyler Event | 23.07.2024

尽管市场环境疲软,但德特威勒在 2024 年上半年提高了利润率并进一步加强了项目储备。

New CEO Volker Cwielong
新闻 | 02.04.2024

Volker Cwielong于2024年4月1日正式接任德特威勒首席执行官。同时,自2017年以来一直担任该职位的Dirk Lambrecht于2024年3月底正式卸任,并于2024年3约14

Innovative collaboration for dielectric elastomer actuators
特别公告. | 05.03.2024

Momentive、Datwyler 和 BSC Computer 将开展深度合作并向工业市场推出了介电弹性体执行器(DEA)创新解决方案。